NCT07232381

Brief Summary

It is aimed to contribute to the Turkish Nutrition Sciences literature and shed light on the studies of future generations by establishing the Turkish validity and reliability of this scale, which was developed for adolescents with type 1 diabetes and their parents and was designed to evaluate general and diabetes-specific nutrition knowledge. Hypotheses:

  • H1: Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is a reliable tool for the Turkish population.
  • H2: Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is a valid tool for the Turkish society.
  • H3: Individuals with higher scores on the Diabetes-Specific Nutrition Information Scale in Adolescents with Type 1 Diabetes have better metabolic control.
  • H4: Diet quality of individuals with higher scores on the Diabetes-Specific Nutrition Information Scale for Adolescents with Type 1 Diabetes is better.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2025

Completed
6 months until next milestone

First Posted

Study publicly available on registry

November 18, 2025

Completed
Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

May 27, 2025

Last Update Submit

March 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Nutritional Knowledge Score

    If your nutritional knowledge score is high your metabolic control is more better

    3 months

Study Arms (2)

Child

The population of the study consists of adolescent individuals with type 1 diabetes between the ages of 10 and 19 who were diagnosed with diabetes at least one year ago. The sample of the study consists of adolescents with type 1 diabetes and their parents, who were followed up for diabetes at Ege University Faculty of Medicine Department of Child Health and Diseases, Pediatric Endocrine Department in Izmir, who met the inclusion criteria for the study and approved the informed consent form.

Parent

The population of the study consists of adolescent individuals with type 1 diabetes between the ages of 10 and 19 who were diagnosed with diabetes at least one year ago. The sample of the study consists of adolescents with type 1 diabetes and their parents, who were followed up for diabetes at Ege University Faculty of Medicine Department of Child Health and Diseases, Pediatric Endocrine Department in Izmir, who met the inclusion criteria for the study and approved the informed consent form.

Eligibility Criteria

Age9 Years - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

adolescents witt type 1 diabetes

You may qualify if:

  • duration of T1D of at least one year,
  • regular follow-up of at least 1 year,
  • no major medical problems (celiac disease, cystic fibrosis, psychiatric disorders, and communication difficulties)
  • the insulin requirement was \> 0.5 IU/kg/day

You may not qualify if:

  • type 1 diabetes duration less than 1 year
  • no regular follow-up of at least 1 year
  • have major medical problems (celiac disease, cystic fibrosis, psychiatric disorders, and communication difficulties) the requirement was \<0.5 IU/kg/day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University, Medical Faculty, Division of Pediatric Endocrinology

Izmir, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
3 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr.Dyt.

Study Record Dates

First Submitted

May 27, 2025

First Posted

November 18, 2025

Study Start

September 1, 2023

Primary Completion

March 30, 2024

Study Completion

July 10, 2024

Last Updated

March 25, 2026

Record last verified: 2026-03

Locations